Search and filter the primary research behind Halo's longevity model — what the evidence shows, how strong it is, and where its limits are — with a link to every original study.
How to read this page
Strong evidence
Moderate evidence
Limited evidence
Evidence quality is graded per record, not for the library as a whole. Each card names the specific reliability or bias concerns that apply — self-report accuracy, reverse causation, confounding — next to the claim they qualify.
These summarise population-level associations. They describe patterns across large groups of people, not a prediction about you specifically.
Never smoker = reference; current smoking ~2.18–2.81× mortality in large cohorts; former smokers can approach never-smoker risk after prolonged cessation
Causal status: Causal support strong; mortality evidence mostly prospective
Reliability / bias notes: Self-report; pack-years and cessation timing matter; reverse causation can affect recent quitters
Each 3-fold (1-SD) higher log-CRP associated with 1.55x non-vascular mortality (95% CI 1.41–1.69) and similar magnitude for vascular mortality, in an individual-participant meta-analysis of 160,309 people across 54 studies
Causal status: Causal role debated; CRP likely partly a marker of underlying inflammation/disease rather than a direct cause
Reliability / bias notes: Association attenuates but persists after adjusting for conventional risk factors and fibrinogen; residual confounding by subclinical illness possible
In nondiabetic adults, glycated hemoglobin showed a J-shaped association with death from any cause, remaining significant after adjustment for fasting glucose, in the ARIC cohort (n=11,092)
Causal status: Causal support strong for diabetes/CVD risk; all-cause mortality relationship J-shaped, so causal direction less clear at low HbA1c
Reliability / bias notes: J-shaped curve means very low HbA1c also carries excess mortality risk, likely reflecting reverse causation/frailty; overlaps with the separate diagnosed-diabetes question, so effects are kept modest to avoid double-counting the same underlying condition
Selvin et al · N Engl J Med · 2010 · PMID 20200384
Adjusted death risk rose stepwise as eGFR fell below 60 mL/min/1.73m2, from HR 1.2 (eGFR 45–59) up to HR 5.9 (eGFR <15), in a cohort of 1.12 million adults
Causal status: Causal support strong; graded, dose-dependent association independent of comorbidities
Reliability / bias notes: Single-measurement creatinine-based eGFR; residual confounding by unmeasured comorbidity possible
1-SD decrement in low-frequency HRV power associated with 1.70x greater all-cause mortality hazard (95% CI 1.37–2.09) over 4 years in an elderly community cohort
Causal status: Associational; reflects autonomic dysfunction, prognostic value shown independent of traditional risk factors
Reliability / bias notes: Older, smaller cohort (n=736, 74 deaths); short 2-hour ECG recording window; results in elderly may not generalize to younger adults